Early detection of infectious bovine keratoconjunctivitis with artificial intelligence.

Vet Res. December 2023;54(1):122.

Shekhar Gupta¹, Larry A Kuehn², Michael L Clawson³

¹ MyAnIML, Overland Park, KS, 66223, USA. shekhar@myaniml.com.; ² United States Department of Agriculture (USDA), Agricultural Research Service (ARS), U. S. Meat Animal Research Center, Clay Center, NE, 68933, USA.; ³ United States Department of Agriculture (USDA), Agricultural Research Service (ARS), U. S. Meat Animal Research Center, Clay Center, NE, 68933, USA. mike.clawson@usda.gov.

Abstract

Artificial intelligence (AI) was developed to distinguish cattle by their muzzle patterns and identify early cases of disease, including infectious bovine keratoconjunctivitis (IBK). It was tested on 870 cattle in four locations, with 170 developing IBK. The AI identified 169 of the 170 cases prior to their identification by veterinarians, and another 17 cases that remained free of IBK signs (sensitivity = 99.4%, specificity = 97.6%). These results indicate the AI can detect emerging IBK cases by muzzle images very early in the disease process and be used as an intervention tool in the prevention of IBK outbreaks.

Keywords

Artificial intelligence; animal welfare; biosecurity; cattle; cattle disease; deep learning; infectious bovine keratoconjunctivitis; muzzles; neural networks; pinkeye;

Article Tools:

Medline

Email to me

Archives Highlights:

Negative pressure wound therapy for the management of surgical site infections with zoonotic, drug-resistant pathogens on the upper body of the horse
Duration of negative pressure wound therapy (NPWT) ranged from 4 to 15?days in five horses, but one horse required NPWT for 70?days due to the large nature of the defect. The NPWT system was easy to use, well-tolerated by patients, and produced acceptable functional and cosmetic outcomes for the clients. By containing wound exudate and reducing daily wound care, it improved hospital biosecurity and reduced exposure to hospital personnel.

Computed tomography findings of nasal cryptococcosis in Australia (2008-2020): 12 dogs and 9 cats.
Dogs were more likely to have a nasal mass, whereas cats were more likely to have a nasopharyngeal mass. Cribriform plate lysis was common in dogs, but not observed in cats. Sinonasal osteolysis was a common feature in both species. Mandibular lymph nodes were commonly enlarged in dogs, whereas in cats, the retropharyngeal lymph nodes were more likely enlarged.

Top Tips for Managing Home and Kennel Infestations With Brown Dog Ticks
Thorough cleaning of the environment to remove tick biomass followed by premise treatment by an experienced exterminator can hasten elimination of ticks. Brown dog ticks are long-lived off the host and may continue to emerge from the structure for many months; a long-term approach is needed to eliminate the population.

Efficacy and safety of once daily oral administration of sodium-glucose cotransporter-2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats.
On Day 45, 29/54 (54%) velagliflozin-treated cats and 26/62 (42%) Caninsulin-treated cats showed treatment success, demonstrating noninferiority. By Day 91, quality of life (QoL), polyuria, and polydipsia had improved in 81%, 54%, and 61% (velagliflozin); on blood glucose (BG) curves, mean BG was <252 mg/dL in 42/54 (78%; velagliflozin) and 37/62 (60%; Caninsulin); minimum BG was <162 mg/dL in 41/54 (76%; velagliflozin) and 41/62 (66%; Caninsulin); serum fructosamine was <450 µmol/L in 41/54 (76%; velagliflozin) and 38/62 (61%; Caninsulin).

Prospective randomized trial comparing relapse rates in dogs with steroid-responsive meningitis-arteritis treated with a 6-week or 6-month prednisolone protocol.
Relapses occurred in 6/20 (30%) of the 6-month protocol and 9/24 (38%) of the 6-week protocol. There was no statistical difference in the incidence risk of at least 1 relapse between the 2 groups. "Short" 6-week prednisolone protocols could be used to treat steroid-responsive meningitis-arteritis, thereby presumably reducing the duration and severity of prednisolone's adverse effects.